Amedisys Inc. (Nasdaq: AMED) warned that second quarter earnings will fall short of expectations prompting a downgrade. The stock price plummeted $8.31 to $26.71.
Amedisys Warns Of Earnings Shortfall
July 13, 2010 at 13:41 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.